Sanofi: For sure the new CETP inhibitor’s failure is good news for PCSK9s and so for Sanofi

BUY, Fair Value EUR103 (+18%)
News published on October Tuesday 13, 2015
Share on

The Essentials

Everything you need to know about investment banking dedicated to growth
Stay Informed
Get our news
Join our Team
Bryan, Garnier & Co is always looking for talent in all our divisions, at all levels
Explore our opportunities